miR-34A expression, epigenetic regulation, and function in human placental diseases

Epigenetics

Volumn 9, Issue 1, 2014, Pages 142-151

  Doridot, Ludivine ^a,b,c   Houry, Dorothée ^a,b,c   Gaillard, Harald ^a,b,c   Chelbi, Sonia T ^a,b,c   Barbaux, Sandrine ^a,b,c   Vaiman, Daniel ^a,b,c  

^a INSTITUT COCHIN   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Intra uterine growth restriction; miR 34a; Placenta; Preeclampsia; SERPINA3

Indexed keywords

MICRORNA 34A; PROTEIN P53; SERINE PROTEINASE INHIBITOR; MICRORNA; MIRN34 MICRORNA, HUMAN; SERPINA3 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CHORIOCARCINOMA; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOXIA; INTRAUTERINE GROWTH RETARDATION; LUCIFERASE ASSAY; MOLECULAR PATHOLOGY; OXYGEN TENSION; PLACENTA DISORDER; PREECLAMPSIA; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ANOXIA; GENETIC EPIGENESIS; GENETICS; METABOLISM; PREGNANCY; TUMOR CELL LINE; UTERUS CANCER;

ANOXIA; CELL LINE, TUMOR; CHORIOCARCINOMA; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; MICRORNAS; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; PROMOTER REGIONS, GENETIC; SERPINS; TUMOR SUPPRESSOR PROTEIN P53; UTERINE NEOPLASMS;

EID: 84890283278     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.26196     Document Type: Article

References (39)

1. Sibai BM. Thrombophilia and severe preeclampsia: time to screen and treat in future pregnancies? Hypertension 2005; 46:1252-3. PMID:16286582; http://dx.doi.org/10.1161/01.HYP.0000188904.47575.7e
2. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308:1592-4. PMID:15947178; http://dx.doi.org/10.1126/science.1111726
3. Astedt B, Lindoff C, Lecander I. Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy. Semin Thromb Hemost 1998; 24:431-5. PMID:9834009; http://dx.doi.org/10.1055/s-2007-996035
4. Chelbi ST, Mondon F, Jammes H, Buffat C, Mignot TM, Tost J, Busato F, Gut I, Rebourcet R, Laissue P, et al. Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension 2007; 49:76-83. PMID:17088445; http://dx.doi.org/10.1161/01.HYP.0000250831.52876.cb
5. Auer J, Camoin L, Guillonneau F, Rigourd V, Chelbi ST, Leduc M, Laparre J, Mignot TM, Vaiman D. Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology. J Proteomics 2010; 73:1004-17. PMID:20079470; http://dx.doi.org/10.1016/j.jprot.2009.12.014
6. Chelbi ST, Wilson ML, Veillard AC, Ingles SA, Zhang J, Mondon F, Gascoin-Lachambre G, Doridot L, Mignot TM, Rebourcet R, et al. Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases. Hum Mol Genet 2012; 21:1968-78. PMID:22246292; http://dx.doi.org/10.1093/hmg/dds006
7. Davis BN, Hata A. Regulation of MicroRNA Biogenesis: A miRiad of mechanisms. Cell Commun Signal 2009; 7:18. PMID:19664273; http://dx.doi.org/10.1186/1478-811X-7-18
8. van Rooij E, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 2007; 117:2369-76. PMID:17786230; http://dx.doi.org/10.1172/JCI33099
9. Cherblanc FL, Davidson RW, Di Fruscia P, Srimongkolpithak N, Fuchter MJ. Perspectives on natural product epigenetic modulators in chemical biology and medicine. Nat Prod Rep 2013; 30:605-24. PMID:23396528; http://dx.doi.org/10.1039/c3np20097c
10. Lee DC, Romero R, Kim JS, Tarca AL, Montenegro D, Pineles BL, Kim E, Lee J, Kim SY, Draghici S, et al. miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestationalage pregnancies. Am J Pathol 2011; 179:590-602. PMID:21801864; http://dx.doi.org/10.1016/j.ajpath.2011.04.035
11. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129:1311-23. PMID:17604720; http://dx.doi.org/10.1016/j.cell.2007.05.022
12. Pang RT, Leung CO, Ye TM, Liu W, Chiu PC, Lam KK, Lee KF, Yeung WS. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 2010; 31:1037-44. PMID:20351093; http://dx.doi.org/10.1093/carcin/bgq066
13. Umemura K, Ishioka S, Endo T, Ezaka Y, Takahashi M, Saito T. Roles of microRNA-34a in the pathogenesis of placenta accreta. J Obstet Gynaecol Res 2013; 39:67-74. PMID:22672425; http://dx.doi.org/10.1111/j.1447-0756.2012.01898.x
14. Kumamoto K, Spillare EA, Fujita K, Horikawa I, Yamashita T, Appella E, Nagashima M, Takenoshita S, Yokota J, Harris CC. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Res 2008; 68:3193-203. PMID:18451145; http://dx.doi.org/10.1158/0008-5472.CAN-07-2780
15. Swiatek PJ, Lindsell CE, del Amo FF, Weinmaster G, Gridley T. Notch1 is essential for postimplantation development in mice. Genes Dev 1994; 8:707-19. PMID:7926761; http://dx.doi.org/10.1101/gad.8.6.707
16. Zhao WX, Lin JH. Notch signaling pathway and human placenta. Int J Med Sci 2012; 9:447-52; http://dx.doi.org/10.7150/ijms.4593
17. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2010; 17:193-9. PMID:19461653; http://dx.doi.org/10.1038/cdd.2009.56
18. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26:731-43. PMID:17540598; http://dx.doi.org/10.1016/j.molcel.2007.05.017
19. Winn VD, Haimov-Kochman R, Paquet AC, Yang YJ, Madhusudhan MS, Gormley M, Feng KT, Bernlohr DA, McDonagh S, Pereira L, et al. Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term. Endocrinology 2007; 148:1059-79. PMID:17170095; http://dx.doi.org/10.1210/en.2006-0683
20. Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M, Post M. Hypoxiainducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest 2000; 105:577-87. PMID:10712429; http://dx.doi.org/10.1172/JCI8316
21. Sdassi N, Silveri L, Laubier J, Tilly G, Costa J, Layani S, Vilotte JL, Le Provost F. Identification and characterization of new miRNAs cloned from normal mouse mammary gland. BMC Genomics 2009; 10:149. PMID:19351399; http://dx.doi.org/10.1186/1471-2164-10-149
22. Yan T, Liu Y, Cui K, Hu B, Wang F, Zou L. MicroRNA-126 regulates EPCs function: Implications for a role of miR-126 in preeclampsia. J Cell Biochem 2013; 114:2148-59. PMID:23553946; http://dx.doi.org/10.1002/jcb.24563
23. Kumar P, Luo Y, Tudela C, Alexander JM, Mendelson CR. The c-Myc-regulated microRNA-17~92 (miR-17~92) and miR-106a~363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation. Mol Cell Biol 2013; 33:1782-96. PMID:23438603; http://dx.doi.org/10.1128/MCB.01228-12
24. Fu G, Brkic J, Hayder H, Peng C. MicroRNAs in Human Placental Development and Pregnancy Complications. Int J Mol Sci 2013; 14:5519-44. PMID:23528856; http://dx.doi.org/10.3390/ijms14035519
25. Wang W, Feng L, Zhang H, Hachy S, Satohisa S, Laurent LC, Parast M, Zheng J, Chen DB. Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17,-20a, and-20b) that target ephrin-B2 and EPHB4 in human placenta. J Clin Endocrinol Metab 2012; 97:E1051-9. PMID:22438230; http://dx.doi.org/10.1210/jc.2011-3131
26. Muralimanoharan S, Maloyan A, Mele J, Guo C, Myatt LG, Myatt L. MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta 2012; 33:816-23. PMID:22840297; http://dx.doi.org/10.1016/j.placenta.2012.07.002
27. Gao WL, Liu M, Yang Y, Yang H, Liao Q, Bai Y, Li YX, Li D, Peng C, Wang YL. The imprinted H19 gene regulates human placental trophoblast cell proliferation via encoding miR-675 that targets Nodal Modulator 1 (NOMO1). RNA Biol 2012; 9:1002-10. PMID:22832245; http://dx.doi.org/10.4161/rna.20807
28. Lázár L, Nagy B, Molvarec A, Szarka A, Rigó J Jr. Role of hsa-miR-325 in the etiopathology of preeclampsia. Mol Med Rep 2012; 6:597-600. PMID:22710575
29. Du R, Sun W, Xia L, Zhao A, Yu Y, Zhao L, Wang H, Huang C, Sun S. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. PLoS One 2012; 7:e30771. PMID:22363487; http://dx.doi.org/10.1371/journal.pone.0030771
30. Forman JJ, Legesse-Miller A, Coller HA. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A 2008; 105:14879-84. PMID:18812516; http://dx.doi.org/10.1073/pnas.0803230105
31. Pang RT, Leung CO, Lee CL, Lam KK, Ye TM, Chiu PC, Yeung WS. MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1. BMC Cancer 2013; 13:25. PMID:23327670; http://dx.doi.org/10.1186/1471-2407-13-25
32. Mondon F, Mignot TM, Rebourcet R, Jammes H, Danan JL, Ferré F, Vaiman D. Profiling of oxygenmodulated gene expression in early human placenta by systematic sequencing of suppressive subtractive hybridization products. Physiol Genomics 2005; 22:99-107. PMID:15797968; http://dx.doi.org/10.1152/physiolgenomics.00276.2004
33. Vaiman D, Mondon F, Garcès-Duran A, Mignot TM, Robert B, Rebourcet R, Jammes H, Chelbi ST, Quetin F, Marceau G, et al. Hypoxia-activated genes from early placenta are elevated in preeclampsia, but not in Intra-Uterine Growth Retardation. BMC Genomics 2005; 6:111. PMID:16129025; http://dx.doi.org/10.1186/1471-2164-6-111
34. Rao DS, O'Connell RM, Chaudhuri AA, Garcia-Flores Y, Geiger TL, Baltimore D. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity 2010; 33:48-59.
35. Kohler PO, Bridson WE, Hammond JM, Weintraub B, Kirschner MA, Van Thiel DH. Clonal lines of human choriocarcinoma cells in culture. Acta Endocrinol Suppl (Copenh) 1971; 153:137-53. PMID:5314233
36. Jeanpierre M. A rapid method for the purification of DNA from blood. Nucleic Acids Res 1987; 15:9611. PMID:3684611; http://dx.doi.org/10.1093/nar/15.22.9611
37. Holemon H, Korshunova Y, Ordway JM, Bedell JA, Citek RW, Lakey N, Leon J, Finney M, McPherson JD, Jeddeloh JA. MethylScreen: DNA methylation density monitoring using quantitative PCR. Biotechniques 2007; 43:683-93. PMID:18072598; http://dx.doi.org/10.2144/000112597
38. Ordway JM, Bedell JA, Citek RW, Nunberg A, Garrido A, Kendall R, Stevens JR, Cao D, Doerge RW, Korshunova Y, et al. Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets. Carcinogenesis 2006; 27:2409-23. PMID:16952911; http://dx.doi.org/10.1093/carcin/bgl161
39. Borghese B, Barbaux S, Mondon F, Santulli P, Pierre G, Vinci G, Chapron C, Vaiman D. Research resource: genome-wide profiling of methylated promoters in endometriosis reveals a subtelomeric location of hypermethylation. Mol Endocrinol 2010; 24:1872-85. PMID:20685852; http://dx.doi.org/10.1210/me.2010-0160